CLBT Cellebrite DI Ltd.
Technology$13.07+0.00%OpenMarket Cap: $3.26B
As of 2026-05-26
Valuation
P/E (TTM)
35.13
PEG
0.28
P/B
6.36
P/S
6.62
EV/EBITDA
26.97
DCF Value
$-0.98
FCF Yield
4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
83.9%
Operating Margin
12.8%
Net Margin
14.5%
ROE
15.5%
ROA
7.5%
ROIC
8.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $128.3M | 82.5% | $9.1M | $10.9M | $— | — |
| Q4 null | $128.8M | 84.7% | $20.8M | $21.3M | $— | — |
| FY null | $475.7M | 84.2% | $66.5M | $78.3M | $— | — |
| Q3 null | $126.0M | 83.9% | $19.0M | $20.2M | $— | — |
| Q2 null | $113.3M | 84.4% | $14.4M | $19.5M | $— | — |
| Q1 null | $107.5M | 83.7% | $12.3M | $17.4M | $— | — |
| Q4 null | $109.0M | 83.8% | $15.7M | $19.3M | $— | — |
| FY null | $401.2M | 84.4% | $56.9M | $-283.0M | $— | — |
| Q3 null | $106.9M | 85.5% | $19.4M | $-207.1M | $— | — |
| Q2 null | $95.7M | 83.0% | $12.5M | $-23.8M | $— | — |
| Q1 null | $89.6M | 85.2% | $9.2M | $-71.4M | $— | — |
| Q4 2023 | $93.0M | 84.0% | $15.0M | $-14.6M | $-0.08 | — |